13F

Stock

Amicus Therapeutics Inc

Ticker not mapped · held by 16 managers

Reported value

$107.5M

Holders

16

+3 new · −0 exited

Holders’ est. mark

$2.28M

Price effect on 5 books still in the name

Largest holder

$56M

BANK OF AMERICA CORP /DE/

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BANK OF AMERICA CORP /DE/7.11M$56MHeld
MORGAN STANLEY3.2M$25.2MHeld
Hudson Bay Capital Management LP2.08M$16.4MHeld
BARCLAYS PLC969.5K$7.64M$2.08MAdded$862.8K
TUDOR INVESTMENT CORP ET AL169K$1.33MHeld
Henshaw Capital LLC43.9K$345.8K$94.3KAdded$42.4K
OP Asset Management Ltd31.4K$247.3K$67.5KAdded$67.5K
FARALLON CAPITAL MANAGEMENT LLC16K$126.1KNew
Leonteq Securities AG13.2K$104.4K$28.5KCut−$29.7K
Swiss Life Asset Management Ltd10.5K$83KNew
Allworth Financial LP4.68K$36.9KHeld
VIRTUS ADVISERS, LLC4.52K$35.6K$9.72KAdded$9.72K
Essential Partners LLC577$4.55KNew
IFP Advisors, Inc214$1.69KHeld
KBC Group NV10.2K$80Held
FNY Investment Advisers, LLC5.46K$43Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.